SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
15523065
Source:
http://linkedlifedata.com/resource/pubmed/id/15523065
Search
Subject
(
39
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0376358
,
umls-concept:C1515985
,
umls-concept:C1522449
pubmed:issue
17
pubmed:dateCreated
2004-11-3
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/15523065-15315996
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/7501160
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Androgen Antagonists
,
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, Hormonal
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
1538-3598
pubmed:author
pubmed-author:FeigenbergSteven JSJ
,
pubmed-author:HanksGerald EGE
,
pubmed-author:HorwitzEric MEM
,
pubmed-author:PollackAlanA
,
pubmed-author:UzzoRobert GRG
pubmed:issnType
Electronic
pubmed:day
3
pubmed:volume
292
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2084-5; author reply 2085
pubmed:dateRevised
2006-11-7
pubmed:meshHeading
pubmed-meshheading:15523065-Androgen Antagonists
,
pubmed-meshheading:15523065-Antineoplastic Agents, Hormonal
,
pubmed-meshheading:15523065-Humans
,
pubmed-meshheading:15523065-Male
,
pubmed-meshheading:15523065-Patient Selection
,
pubmed-meshheading:15523065-Prostatic Neoplasms
,
pubmed-meshheading:15523065-Radiotherapy, Conformal
,
pubmed-meshheading:15523065-Survival Analysis
pubmed:year
2004
pubmed:articleTitle
Androgen suppression plus radiation therapy for prostate cancer.
pubmed:publicationType
Letter
,
Comment